CytoNest, Inc.

CytoNest, Inc. is a biotechnology startup with a focus on cell nesting technologies. Their flagship product, the CytoSurge™ 3D fiber scaffold, aims to revolutionize adherent cell manufacturing for various applications such as 3D cell culture, tissue engineering, regenerative medicine, biopharmaceuticals, cultured meat, and cultured seafood. The company's scaffolds are made from biocompatible and/or edible biomaterials, allowing for efficient growth of adherent cells at high densities. CytoNest, Inc. seeks to maintain cell-surface interactions and cell-specific biochemical and structural environments by incorporating innovative 3D scaffolding approaches.

Founded in 2020, CytoNest, Inc. operates within the biotechnology, life sciences, manufacturing, and medical devices industries. The company utilizes a unique and proprietary fiber fabrication technology, initially developed by the founders at the Nanostructured Materials Lab at the University of Georgia.

As of now, there is no available information on the company's headquarter location or their last investment and associated investors. However, CytoNest, Inc.'s focus on leveraging advanced fiber scaffold technology for various cell culture and medical applications presents an intriguing opportunity for potential investors interested in the biotechnology and life sciences sectors.